GSK establishes Asia HQ in Singapore
All employees currently based in Gateway West will move to the new headquarters during the second half of 2017, once the site is fully fitted
GlaxoSmithKline (GSK) is to strengthen its presence in Singapore by establishing a new global headquarters for Asia. This would further expand its commitment to patients and consumers in the region, the company said. GSK has signed an agreement with Boustead Development Partnership, in a joint venture entity, to develop and lease a new building.
GSK will move all employees currently based in Gateway West to the new headquarters during the second half of 2017, once the site is fully fitted. CEO Sir Andrew Witty said: 'GSK's and Singapore’s histories are entwined. Since building our first site at Quality Road in 1972, we have continued to significantly expand our footprint, capability and talent base. In our experience and my own personal experience, Singapore excels in fostering talent, supporting business growth and offers an excellent base to access Asia.
'This is why we are making a significant decision to further increase our presence in Singapore as we continue to modernise and advance GSK.' GSK has been present in Asia for more than 40 years. The new global headquarters for Asia will support local GSK businesses across the region by providing relevant expertise, capability and services, the company added.
'Singapore is heartened that GSK chose Singapore as the home for its global headquarters for Asia, and has decided to establish a new headquarters building here,' said Dr Beh Swan Gin, chairman of the Singapore Economic Development Board, at the opening. 'Its decision is testimony to our value proposition as a trusted biomedical sciences hub, where companies can access global talent and build strategic capabilities to spearhead their growth in the region.'
